Document is current
Any future updates will be listed below
-
Authors
Munawar, Umair
Zhou, Xiang
Prommersberger, Sabrina
Nerreter, Silvia
Vogt, Cornelia
Steinhardt, Maximilian J. https://orcid.org/0000-0003-3644-9187
Truger, Marietta
Mersi, Julia
Teufel, Eva
Han, Seungbin
Haertle, Larissa https://orcid.org/0000-0002-3927-9163
Banholzer, Nicole
Eiring, Patrick
Danhof, Sophia https://orcid.org/0000-0003-1316-0241
Navarro-Aguadero, Miguel Angel
Fernandez-Martin, Adrian
Ortiz-Ruiz, Alejandra https://orcid.org/0000-0003-4059-8839
Barrio, Santiago
Gallardo, Miguel https://orcid.org/0000-0002-3699-9130
Valeri, Antonio
Castellano, Eva
Raab, Peter
Rudert, Maximilian
Haferlach, Claudia
Sauer, Markus https://orcid.org/0000-0002-1692-3219
Hudecek, Michael https://orcid.org/0000-0002-2280-2202
Martinez-Lopez, J.
Waldschmidt, Johannes
Einsele, Hermann https://orcid.org/0000-0002-7680-0819
Rasche, Leo https://orcid.org/0000-0002-9536-9649
Kortüm, K. Martin https://orcid.org/0000-0002-7011-0286
-
Funding
Funding for this research was provided by:
Stiftung zur Förderung der Krebsforschung an der Universität Würzburg Stifterverband CDW Stiftung Janssen Deutsche Krebshilfe Mildred Scheel Early Career Center
- License Information
-
More Information
Article History
Received: 3 July 2023
Accepted: 6 December 2023
First Online: 21 December 2023
Competing interests
: The authors declare the following competing interests: K.M.K. reports other support from Stifterverband für die Deutsche Wissenschaft, personal fees from Celgene, BMS, AbbVie, GSK, and Takeda; grants and personal fees from Janssen; and grants from SkylineDx and German Cancer Aid—MSNZ. C.H. reports other support from MLL Munich Leukemia Laboratory. J.M.-L. reports personal fees and nonfinancial support from Janssen, Sanofi, BMS, Roche and Gilead. H.E. reports grants and other support from Janssen, BMS/Celgene, Amgen, GSK, and Sanofi, as well as other support from Takeda and Novartis. L.R. reports personal fees from BMS, Janssen, Pfizer, Amgen, GSK, Sanofi and support from German Cancer Aid—MSNZ. Other authors declare no competing interests.
